Poseida Therapeutics Inc (PSTX) with a beta value of 0.40 appears to be a promising investment opportunity.
On Monday, Poseida Therapeutics Inc (NASDAQ: PSTX) was -10.99% down from the session before settling in for the closing price of $2.73. A 52-week range